{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:10:36Z","timestamp":1794625836782,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2506502"],"award-info":[{"award-number":["2023YFC2506502"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220818103407015; GJHZ20240218113401003"],"award-info":[{"award-number":["JCYJ20220818103407015; GJHZ20240218113401003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03175-3","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:15:37Z","timestamp":1775974537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index (CTI) versus the cholesterol, high-density lipoprotein, and glucose index (CHG) for incident hypertension prediction: a national cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jiaqing","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"issue":"10513","key":"3175_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","volume":"406","author":"GBD 2023 Causes of Death Collaborators","year":"2025","unstructured":"GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the global burden of disease study 2023. The Lancet. 2025;406(10513):1811\u201372. https:\/\/doi.org\/10.1016\/S0140-6736(25)01917-8.","journal-title":"The Lancet"},{"issue":"10112","key":"3175_CR2","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE Million Persons Project). The Lancet. 2017;390(10112):2549\u201358. https:\/\/doi.org\/10.1016\/S0140-6736(17)32478-9.","journal-title":"The Lancet"},{"key":"3175_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijcard.2016.10.110","volume":"227","author":"Y Li","year":"2017","unstructured":"Li Y, et al. Burden of hypertension in China: a nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516\u201323. https:\/\/doi.org\/10.1016\/j.ijcard.2016.10.110.","journal-title":"Int J Cardiol"},{"key":"3175_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1620585","volume":"16","author":"H Solleiro-Villavicencio","year":"2025","unstructured":"Solleiro-Villavicencio H, et al. Inflammation: a key mechanism connecting metabolic-associated steatotic liver disease and systemic arterial hypertension. Front Immunol. 2025;16:1620585. https:\/\/doi.org\/10.3389\/fimmu.2025.1620585.","journal-title":"Front Immunol"},{"issue":"1","key":"3175_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02492-y","volume":"24","author":"Z Guo","year":"2025","unstructured":"Guo Z, et al. Association between metabolic score for insulin resistance (METS-IR) and hypertension: a cross-sectional study based on NHANES 2007-2018. Lipids Health Dis. 2025;24(1):64. https:\/\/doi.org\/10.1186\/s12944-025-02492-y.","journal-title":"Lipids Health Dis"},{"key":"3175_CR6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01118.2006","author":"EA Ko","year":"2007","unstructured":"Ko EA, et al. Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. American J Physiol Heart Circulatory Physiol. 2007. https:\/\/doi.org\/10.1152\/ajpheart.01118.2006.","journal-title":"American J Physiol Heart Circulatory Physiol"},{"issue":"2","key":"3175_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.amjmed.2024.09.003","volume":"138","author":"Y Saiki","year":"2025","unstructured":"Saiki Y, et al. Smoking cessation and the odds of developing hypertension in a working-age male population: the impact of body weight changes. Am J Med. 2025;138(2):245-253.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2024.09.003.","journal-title":"Am J Med"},{"issue":"2","key":"3175_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37936","volume":"4","author":"RV Levy","year":"2021","unstructured":"Levy RV, et al. Analysis of active and passive tobacco exposures and blood pressure in US children and adolescents. JAMA Netw Open. 2021;4(2):e2037936. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37936.","journal-title":"JAMA Netw Open"},{"key":"3175_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-025-07739-5","author":"MR Akanda","year":"2025","unstructured":"Akanda MR, et al. Molecular interplay of gene network dynamics, epigenetic regulation, and therapeutic mapping in cardiovascular disease. Cardiovasc Drugs Ther. 2025. https:\/\/doi.org\/10.1007\/s10557-025-07739-5.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"3175_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/jdi.14343","volume":"16","author":"A Mansoori","year":"2025","unstructured":"Mansoori A, et al. A novel index for diagnosis of type 2 diabetes mellitus: cholesterol, High density lipoprotein, and Glucose (CHG) index. J diabetes investigation. 2025;16(2):309\u201314. https:\/\/doi.org\/10.1111\/jdi.14343.","journal-title":"J diabetes investigation"},{"issue":"1","key":"3175_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03104-4","volume":"25","author":"Y Song","year":"2026","unstructured":"Song Y, et al. The cholesterol, high-density lipoprotein, and glucose (CHG) index as a novel metabolic marker for predicting adverse outcomes in myocardial infarction survivors: insights from two large prospective cohorts. Cardiovasc Diabetol. 2026;25(1):80. https:\/\/doi.org\/10.1186\/s12933-026-03104-4.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02906-2","volume":"24","author":"Z Guo","year":"2025","unstructured":"Guo Z, et al. Association between cholesterol, high-density lipoprotein, and glucose index and risks of cardiovascular and all-cause mortality in patients with calcific aortic valve stenosis: the ARISTOTLE cohort study. Cardiovasc Diabetol. 2025;24(1):393. https:\/\/doi.org\/10.1186\/s12933-025-02906-2.","journal-title":"Cardiovasc Diabetol"},{"key":"3175_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/dom.70338","author":"R Tian","year":"2025","unstructured":"Tian R, et al. Association of cumulative exposure to cholesterol, high-density lipoprotein, and glucose index with the risk of cardiovascular disease and all-cause mortality: a longitudinal cohort study. Diabetes Obes Metab. 2025. https:\/\/doi.org\/10.1111\/dom.70338.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"3175_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/00368504251396781","volume":"108","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, et al. The relationship between cholesterol, high-density lipoprotein, and glucose index and hypertension: a study based on two national cohorts. Sci Prog. 2025;108(4):368504251396781. https:\/\/doi.org\/10.1177\/00368504251396781.","journal-title":"Sci Prog"},{"key":"3175_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"G-T Ruan","year":"2022","unstructured":"Ruan G-T, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol. 2022;13:905266. https:\/\/doi.org\/10.3389\/fendo.2022.905266.","journal-title":"Front Endocrinol"},{"issue":"1","key":"3175_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, et al. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24(1):316. https:\/\/doi.org\/10.1186\/s12933-025-02876-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03081-8","volume":"25","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, et al. Association of cumulative cholesterol-HDL-glucose index with blood pressure changes and risk of new-onset hypertension in middle-aged and older adults: a cohort study. Cardiovasc Diabetol. 2026;25(1):49. https:\/\/doi.org\/10.1186\/s12933-026-03081-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, et al. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3175_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02945-9","volume":"24","author":"Y Yang","year":"2025","unstructured":"Yang Y, Liu A. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident stroke in middle-aged and older Chinese adults: a longitudinal analysis based on CHARLS. Cardiovasc Diabetol. 2025;24(1):386. https:\/\/doi.org\/10.1186\/s12933-025-02945-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02869-4","volume":"24","author":"X Ma","year":"2025","unstructured":"Ma X, et al. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):303.","journal-title":"Cardiovasc Diabetol"},{"key":"3175_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1320918","volume":"12","author":"Z-J Niu","year":"2024","unstructured":"Niu Z-J, et al. The effect of insulin resistance in the association between obesity and hypertension incidence among Chinese middle-aged and older adults: data from China health and retirement longitudinal study (CHARLS). Front Public Health. 2024;12:1320918. https:\/\/doi.org\/10.3389\/fpubh.2024.1320918.","journal-title":"Front Public Health"},{"issue":"6","key":"3175_CR22","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s11606-022-07951-1","volume":"38","author":"L Ding","year":"2023","unstructured":"Ding L, et al. The association of age at diagnosis of hypertension with cognitive decline: the China health and retirement longitudinal study (CHARLS). J Gen Intern Med. 2023;38(6):1431\u20138. https:\/\/doi.org\/10.1007\/s11606-022-07951-1.","journal-title":"J Gen Intern Med"},{"issue":"38","key":"3175_CR23","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"issue":"4","key":"3175_CR24","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/met.2008.0034","volume":"6","author":"LE Simental-Mend\u00eda","year":"2008","unstructured":"Simental-Mend\u00eda LE, et al. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299\u2013304. https:\/\/doi.org\/10.1089\/met.2008.0034.","journal-title":"Metab Syndr Relat Disord"},{"key":"3175_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jesp.2013.03.013","volume":"49","author":"C Leys","year":"2013","unstructured":"Leys C, et al. Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49:764\u20136. https:\/\/doi.org\/10.1016\/j.jesp.2013.03.013.","journal-title":"J Exp Soc Psychol"},{"issue":"4","key":"3175_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374. https:\/\/doi.org\/10.7326\/M16-2607.","journal-title":"Ann Intern Med"},{"issue":"1","key":"3175_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12010165","volume":"12","author":"A Garc\u00eda-S\u00e1nchez","year":"2023","unstructured":"Garc\u00eda-S\u00e1nchez A, et al. Prevalence of hypertension and obesity: profile of mitochondrial function and markers of inflammation and oxidative stress. Antioxidants. 2023;12(1):165. https:\/\/doi.org\/10.3390\/antiox12010165.","journal-title":"Antioxidants"},{"issue":"8","key":"3175_CR28","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/cvr\/cvaa336","volume":"117","author":"JE Hall","year":"2021","unstructured":"Hall JE, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021;117(8):1859\u201376. https:\/\/doi.org\/10.1093\/cvr\/cvaa336.","journal-title":"Cardiovasc Res"},{"key":"3175_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104964","volume":"100","author":"W Liu","year":"2024","unstructured":"Liu W, et al. Major lipids and lipoprotein levels and risk of blood pressure elevation: a Mendelian randomisation study. EBioMedicine. 2024;100:104964. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104964.","journal-title":"EBioMedicine"},{"issue":"5","key":"3175_CR30","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/s41440-023-01233-x","volume":"46","author":"I Usui","year":"2023","unstructured":"Usui I. Common metabolic features of hypertension and type 2 diabetes. Hypertens Res. 2023;46(5):1227\u201333. https:\/\/doi.org\/10.1038\/s41440-023-01233-x.","journal-title":"Hypertens Res"},{"issue":"1","key":"3175_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02591-1","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, et al. The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol. 2025;24(1):47. https:\/\/doi.org\/10.1186\/s12933-025-02591-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-25261-z","volume":"25","author":"Z Wu","year":"2025","unstructured":"Wu Z, et al. Cumulative triglyceride-glucose index and hypertension risk: a longitudinal cohort study. BMC Public Health. 2025;25(1):4048. https:\/\/doi.org\/10.1186\/s12889-025-25261-z.","journal-title":"BMC Public Health"},{"issue":"1","key":"3175_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02571-x","volume":"24","author":"Y Huang","year":"2025","unstructured":"Huang Y, et al. Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohorts. Cardiovasc Diabetol. 2025;24(1):11. https:\/\/doi.org\/10.1186\/s12933-024-02571-x.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02087-w","volume":"22","author":"F Xin","year":"2023","unstructured":"Xin F, et al. The triglyceride glucose index trajectory is associated with hypertension: a retrospective longitudinal cohort study. Cardiovasc Diabetol. 2023;22(1):347. https:\/\/doi.org\/10.1186\/s12933-023-02087-w.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3175_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cjca.2020.02.066","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva AA, et al. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36(5):671\u201382. https:\/\/doi.org\/10.1016\/j.cjca.2020.02.066.","journal-title":"Can J Cardiol"},{"issue":"6","key":"3175_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","volume":"116","author":"JE Hall","year":"2015","unstructured":"Hall JE, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991\u20131006. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.305697.","journal-title":"Circ Res"},{"issue":"8","key":"3175_CR37","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/CIRCRESAHA.111.258673","volume":"111","author":"C Mineo","year":"2012","unstructured":"Mineo C, Shaul PW. Novel biological functions of high-density lipoprotein cholesterol. Circ Res. 2012;111(8):1079\u201390. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.258673.","journal-title":"Circ Res"},{"issue":"8","key":"3175_CR38","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jacc.2003.10.061","volume":"43","author":"A Scuteri","year":"2004","unstructured":"Scuteri A, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004;43(8):1388\u201395. https:\/\/doi.org\/10.1016\/j.jacc.2003.10.061.","journal-title":"J Am Coll Cardiol"},{"issue":"7121","key":"3175_CR39","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"G\u00f6khanS Hotamisligil","year":"2006","unstructured":"Hotamisligil G\u00f6khanS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860\u20137. https:\/\/doi.org\/10.1038\/nature05485.","journal-title":"Nature"},{"issue":"1","key":"3175_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2023.2210785","volume":"45","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Neutrophil and monocyte ratios to high-density lipoprotein cholesterol as biomarkers in non-dipping hypertension. Clin Exp Hypertens. 2023;45(1):2210785. https:\/\/doi.org\/10.1080\/10641963.2023.2210785.","journal-title":"Clin Exp Hypertens"},{"issue":"19","key":"3175_CR41","doi-asserted-by":"publisher","first-page":"9012","DOI":"10.26355\/eurrev_202310_33925","volume":"27","author":"B Demirta\u015f","year":"2023","unstructured":"Demirta\u015f B, Aydin T. Monocyte-to-high-density lipoprotein ratio: an independent predictor of reverse dipper pattern in hypertensive patients. Eur Rev Med Pharmacol Sci. 2023;27(19):9012\u201321. https:\/\/doi.org\/10.26355\/eurrev_202310_33925.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3175_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01599-1","volume":"21","author":"S Tai","year":"2022","unstructured":"Tai S, et al. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):161. https:\/\/doi.org\/10.1186\/s12933-022-01599-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01967-5","volume":"22","author":"H Zheng","year":"2023","unstructured":"Zheng H, et al. Relationship between cumulative exposure to triglyceride-glucose index and heart failure: a prospective cohort study. Cardiovasc Diabetol. 2023;22(1):239. https:\/\/doi.org\/10.1186\/s12933-023-01967-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02754-0","volume":"24","author":"L Lu","year":"2025","unstructured":"Lu L, et al. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):202. https:\/\/doi.org\/10.1186\/s12933-025-02754-0.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02114-w","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23(1):16. https:\/\/doi.org\/10.1186\/s12933-023-02114-w.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3175_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02350-8","volume":"23","author":"Z Liu","year":"2024","unstructured":"Liu Z, et al. The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study. Cardiovasc Diabetol. 2024;23(1):264. https:\/\/doi.org\/10.1186\/s12933-024-02350-8.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3175_CR47","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1111\/dom.14492","volume":"23","author":"G Fauchier","year":"2021","unstructured":"Fauchier G, et al. Metabolically healthy obesity and cardiovascular events: a nationwide cohort study. Diabetes Obes Metab. 2021;23(11):2492\u2013501. https:\/\/doi.org\/10.1111\/dom.14492.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"3175_CR48","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.numecd.2022.06.010","volume":"32","author":"B Abiri","year":"2022","unstructured":"Abiri B, et al. Transition from metabolically healthy to unhealthy overweight\/obesity and risk of cardiovascular disease incidence: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32(9):2041\u201351. https:\/\/doi.org\/10.1016\/j.numecd.2022.06.010.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"4","key":"3175_CR49","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cmet.2024.03.002","volume":"36","author":"MC Petersen","year":"2024","unstructured":"Petersen MC, et al. Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. Cell Metab. 2024;36(4):745-761.e5. https:\/\/doi.org\/10.1016\/j.cmet.2024.03.002.","journal-title":"Cell Metab"},{"issue":"4","key":"3175_CR50","doi-asserted-by":"publisher","first-page":"e1103","DOI":"10.1210\/clinem\/dgae341","volume":"110","author":"AW Potter","year":"2025","unstructured":"Potter AW, et al. defining overweight and obesity by percent body fat instead of body mass index. J Clin Endocrinol Metab. 2025;110(4):e1103\u20137. https:\/\/doi.org\/10.1210\/clinem\/dgae341.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3175_CR51","doi-asserted-by":"publisher","DOI":"10.2196\/26233","volume":"9","author":"S Payne Riches","year":"2021","unstructured":"Payne Riches S, et al. A mobile health salt reduction intervention for people with hypertension: results of a feasibility randomized controlled trial. JMIR Mhealth Uhealth. 2021;9(10):e26233. https:\/\/doi.org\/10.2196\/26233.","journal-title":"JMIR Mhealth Uhealth"},{"key":"3175_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.134398","volume":"299","author":"Z Weng","year":"2022","unstructured":"Weng Z, et al. Associations of genetic risk factors and air pollution with incident hypertension among participants in the UK Biobank study. Chemosphere. 2022;299:134398. https:\/\/doi.org\/10.1016\/j.chemosphere.2022.134398.","journal-title":"Chemosphere"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03175-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:28:18Z","timestamp":1779409698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03175-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3175"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03175-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8819257\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CHARLS study was approved by the Institutional Review Board of Peking University (IRB00001052-11015 for the household survey and IRB00001052-11014 for blood samples). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}